OTC Pharmaceuticals - Montenegro

  • Montenegro
  • Revenue in the OTC Pharmaceuticals market amounts to US$24.48m in 2024. The market is expected to grow annually by 4.95% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$6.97m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$39.10 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Montenegro has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in Montenegro have shifted towards self-medication and the use of over-the-counter (OTC) pharmaceutical products.

This trend can be attributed to several factors, including increasing consumer awareness about healthcare and a growing preference for convenience. Consumers in Montenegro are increasingly seeking quick and easy solutions for minor ailments and prefer to purchase OTC medications without the need for a doctor's prescription. This preference for self-medication has led to an increased demand for OTC pharmaceutical products in the market.

In line with global trends, Montenegro has also witnessed a rise in the popularity of natural and herbal remedies. Consumers are increasingly seeking OTC pharmaceutical products that are perceived to be more natural and have fewer side effects. This trend can be attributed to a growing interest in alternative medicine and a desire for more holistic approaches to healthcare.

As a result, there has been an increase in the availability and variety of natural and herbal OTC pharmaceutical products in the market. Another notable trend in the OTC Pharmaceuticals market in Montenegro is the increasing focus on preventive healthcare. Consumers are becoming more proactive in managing their health and are willing to invest in OTC pharmaceutical products that can help prevent illnesses and maintain overall well-being.

This trend can be attributed to a growing emphasis on health and wellness, as well as an aging population that is more conscious of their health needs. As a result, there has been a rise in the demand for OTC pharmaceutical products such as vitamins, supplements, and preventive medications. Local special circumstances in Montenegro have also contributed to the development of the OTC Pharmaceuticals market.

The country has a well-established healthcare system that provides universal access to healthcare services. However, due to limited resources and long waiting times, many consumers prefer to self-medicate for minor ailments. This has created a favorable environment for the growth of the OTC Pharmaceuticals market, as consumers have easy access to a wide range of OTC products.

Underlying macroeconomic factors, such as a stable economy and increasing disposable income, have also played a role in the development of the OTC Pharmaceuticals market in Montenegro. As the economy continues to grow, consumers have more purchasing power and are willing to spend on healthcare products. This has led to an increase in the demand for OTC pharmaceutical products, as consumers are able to afford these products and are willing to invest in their health.

In conclusion, the OTC Pharmaceuticals market in Montenegro is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the popularity of natural and herbal remedies, and the focus on preventive healthcare are driving the growth of the market. Additionally, the country's well-established healthcare system and favorable macroeconomic conditions have created a conducive environment for the development of the OTC Pharmaceuticals market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)